Reporter gene transactivation by human p53 is inhibited in thioredoxin reductase null yeast by a mechanism associated with thioredoxin oxidation and independent of changes in the redox state of glutathione

Carcinogenesis

Volumn 23, Issue 10, 2002, Pages 1609-1615

  Merwin, J R ^a   Mustacich, D J ^a   Muller, E G D ^b   Pearson, G D ^a   Merrill, G F ^a  

^a OREGON STATE UNIVERSITY   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISULFIDE; GLUTATHIONE; PROTEIN P53; THIOREDOXIN; THIOREDOXIN REDUCTASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE MUTATION; GENETIC CODE; GLUTATHIONE METABOLISM; INHIBITION KINETICS; NONHUMAN; OXIDATION; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROTEIN FUNCTION; REPORTER GENE; SACCHAROMYCES CEREVISIAE; TRANSACTIVATION; WILD TYPE;

DISULFIDES; GENE DELETION; GENES, P53; GLUTATHIONE; GLUTATHIONE DISULFIDE; HUMANS; OXIDATION-REDUCTION; SACCHAROMYCES CEREVISIAE; SULFHYDRYL COMPOUNDS; THIOREDOXIN; THIOREDOXIN REDUCTASE (NADPH); TRANS-ACTIVATION (GENETICS); TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036797413     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Avram, D. and Bakalinsky, A.T. (1997) SSU1 encodes a plasma membrane protein with a central role in a network of proteins conferring sulfite tolerance in Saccharomyces cerevisiae. J. Bacteriol., 179, 5971-5974.
2. Berggren, M., Gallegos, A., Gasdaska, J. and Powis, G. (1997) Cellular thioredoxin reductase activity is regulated by selenium. Anticancer Res., 17, 3377-3380.
3. Bersani, N.A., Merwin, J.R., Lopez, N.I., Pearson, G.D. and Merrill, G.F. (2002) Protein electrophoretic mobility shift assay to monitor redox state of thioredoxin in cells. Meth. Enzymol., 347, 317-326.
4. Bösl, M.R., Takaku, K., Oshima, M., Nishimura, S. and Taketo, M.M. (1997) Early embryonic lethality caused by targeted disruption of the mouse selenocysteine tRNA gene (Trsp). Proc. Natl Acad. Sci. USA, 94, 5531-5534.
5. Bradford, M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
6. Carmel-Harel, O., Stearman, R., Gasch, A.P., Botstein, D., Brown, P.O. and Storz, G. (2001) Role of thioredoxin reductase in the Yap1p-dependent response to oxidative stress in Saccharomyces cerevisiae. Mol. Microbiol., 39, 595-605.
7. Casso, D. and Beach, D. (1996) A mutation in a thioredoxin reductase homolog suppresses p53-induced growth inhibition in the fission yeast Schizosaccharomyces pombe. Mol. Gen. Genet., 252, 518-529.
8. Chae, H.Z., Chung, S.J. and Rhee, S.G. (1994) Thioredoxin dependent peroxide reductase from yeast. J. Biol. Chem., 269, 27670-27678.
9. Cho, Y., Gorina, S. Jeffrey, P.D. and Pavletich, N.P. (1994) Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science, 265, 346-355.
10. Clark, L.C., Dalkin, B.A. Krongrad, G.F., et al. 1998. Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. Br. J. Urol., 81, 730-734.
11. Delphin, C., Cahen, P., Lawrence, J.J. and Baudier, J. (1994) Characterization of baculovirus recombinant wild-type p53. Dimerization of p53 is required for high-affinity DNA binding and cysteine oxidation inhibits p53 DNA binding. Eur. J. Biochem., 223, 683-692.
12. Fariss, M.W. and Reed, D.J. (1987) High-performance liquid chromatography of thiols and disulfides: dinitrophenol derivatives. Meth. Enzymol., 143, 101-109.
13. Geitz, R.D. and Sugino, A. (1988) New yeast-Escherischia coli shuttle vectors constructed with in vitro mutagenized yeast genes lacking six-base pair restriction sites. Gene, 74, 527-534.
14. Gladyshev, V.N. and Hatfield, D.L. (1999) Selenocysteine-containing proteins in mammals. J. Biomed. Sci., 6, 151-160.
15. Gladyshev, V.N., Jeang, K.T. and Stadtman, T.C. (1996) Selenocysteine, identified as the penultimate C-terminal residue in human T-cell thioredoxin reductase, corresponds to TGA in the human placental gene. Proc. Natl Acad. Sci. USA, 93, 6146-6151.
16. Graeber, T.G., Osmanian, C., Jacks, T., Housman, D.E., Koch, C.J., Lowe, S.W. and Giaccia, A.J. (1996) Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature, 379, 88-91.
17. Grant, C.M., Collinson, L.P., Roe, J.-H. and Dawes, I.W. (1996) Yeast glutathione reductase is required for protection against oxidative stress and is a target for yAP-1 transcriptional regulation. Mol. Microbiol., 21, 171-179.
18. Gu, W., Shi, X.L. and Roeder, R.G. (1997) Synergistic activation of transcription by CBP and p53. Nature, 387, 819-823.
19. Hainaut, P. and Mann, K. (2001) Zinc binding and redox control of p53 structure and function. Antiox. Redox Signal., 3, 611-623.
20. Hainaut, P. and Milner, J. (1993) Redox modulation of p53 conformation and sequence-specific DNA binding in vitro. Cancer Res., 53, 4469-4473.
21. Holmgren, A. (1977) Bovine thioredoxin system. Purification of thioredoxin reductase from calf liver and thymus and studies of its function in disulfide reduction. J. Biol. Chem., 252, 4600-4606.
22. Jayaraman, L., Murthy, K.G., Zhu, C., Curran, T., Xanthoudakis, S. and Prives, C. (1997) Identification of redox/repair protein Ref-1 as a potent activator of p53. Genes Der., 11, 558-570.
23. Kippert, F. (1995) A rapid permeabilization procedure for accurate quantitative determination of beta-galactosidase activity in yeast cells. FEMS Microbiol. Lett., 128, 201-206.
24. Koumenis, C., Alarcon, R.E., Hammond, P., et al. (2001) Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation. Mol. Cell. Biol., 21, 1297-1310.
25. Lill, N.L., Grossman, S.R., Ginsberg, D., DeCaprio, J. and Livingston, D.M. (1997) Binding and modulation of p53 by p300/CBP coactivators. Nature, 387, 823-827.
26. Machado, A.K., Morgan, B.A. and Merrill, G.M. (1997) Thioredoxin reductase-dependent inhibition of MCB cell cycle box activity in Saccharomyces cerevisiae. J. Biol. Chem., 272, 17045-17054.
27. Matsui, M., Oshima, M., Oshima, H., Takaku, K., Maruyama, T., Yodoi, J. and Taketo, M.M. (1996) Early embryonic lethality caused by targeted disruption of the mouse thioredoxin gene. Dev. Biol., 178, 179-185.
28. Matthews, J.R., Wakasugi, N., Virelizier J.-L.V., Yodoi, J. and Hay, R.T. (1992) Thioredoxin regulates the DNA binding activity of NF-kB by reduction of a disulfide bond involving cysteine 62. Nucleic Acids Res., 20, 3821-3830.
29. Merrill, G.M., Dowell, P. and Pearson, G.D. (1999) The human p53 negative regulatory domain mediates inhibition of reporter gene transactivation in yeast lacking thioredoxin reductase. Cancer Res., 59, 3175-3179.
30. Muller, E.G.D. (1996) A glutathione reductase mutant of yeast accumulates high levels of oxidized glutathione and requires thioredoxin for growth. Mol. Biol. Cell, 7, 1805-1813.
31. Muller, E.G.D. (1994) A redox-dependent function of thioredoxin is necessary to sustain a rapid rate of DNA synthesis in yeast. Arch. Biochem. Biophys., 318, 356-361.
32. Mumberg, D., Muller, R. and Funk, M. (1995) Yeast vectors for the controlled expression of heterologous proteins in different genetic backgrounds. Gene, 156, 119-122.
33. Mustacich, D. and Powis, G. (2000) Thioredoxin reductase. Biochem. J., 346, 1-8.
34. Pearson, G.D. and Merrill, G.F. (1998) Deletion of the Saccharomyces cerevisiae TRR1 gene encoding thioredoxin reductase inhibits p53-dependent reporter gene expression. J. Biol. Chem., 273, 5431-5434.
35. Powis, G. and Montfort, W.R. (2001) Properties and biological activities of thioredoxins. Ann. Rev Pharmacol Toxicol., 41, 261-295.
36. Qin, J., Clore, G.M., Kennedy, W.M., Huth, J.R. and Gronenborn, A.M. (1995) Solution structure of human thioredoxin in a mixed disulfide intermediate complex with its target peptide from the transcription factor NF kappa B. Structure, 3, 289-297.
37. Rainwater, R., Parks, D. Anderson, M.E., Tegtmeyer, P. and Mann, K. (1995) Role of cysteine residues in regulation of p53 function. Mol. Cell. Biol., 15, 3892-3903.
38. Rose, M.D., Winston, F. and Hieter, P. (1990) Methods in Yeast Genetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
39. Sikorski, R. and Hieter, P. (1989) A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae. Genetics, 122, 19-27.
40. Takahashi, N. and Hirose, M. (1990) Determination of sulfhydryl groups and disulfide bonds in a protein by polyacrylamide gel electrophoresis. Anal. Biochem., 188, 359-365.
41. Thiagalingam, S., Kinzler, K.W. and Vogelstein, B. (1995) PAK1, a gene that can regulate p53 activity in yeast. Proc. Natl Acad. Sci. USA, 92, 6062-6066.
42. Ueno, M., Masutani, R.J., Arai, A., et al. (1999) Thioredoxin-dependent redox regulation of p53-mediated p21 activation. J. Biol. Chem., 274, 35809-35815.
43. Verhaegh, G.W., Richard, M.J. and Hainaut, P. (1997) Regulation of p53 by metal ions and by antioxidants: dithiocarbamate down-regulates p53 DNA-binding activity by increasing the intracellular level of copper. Mol. Cell. Biol., 17, 5699-706.
44. Wallis, J.W., Chrebet, G., Brodsky, G., Rolfe, M. and Rothstein, R. (1989) A hyper-recombination mutation in S. cerevisiae identifies a novel eucaryotic topoisomerase. Cell, 58, 409-419.
45. Wu, H.H. and Momand, J. (1998) Pyrrolidine dithiocarbamate prevents p53 activation and promotes p53 cysteine residue oxidation. J. Biol. Chem., 273, 18898-18905.
46. Xu, X., Wightman, J.D., Geller, B.L., Avram, D. and Bakalinsky, A.T. (1994) Isolation and characterization of sulfite mutants of Saccharomyces cerevisiae. Curr. Genet., 25, 488-496.